¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"myel"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • myelophthisic splenomegaly
    °ñ¼ö·Î¼ººñÀåºñ´ë
  • myelophthisis
    1. ô¼öȲÆó(Áõ) 2. °ñ¼öȲÆó(Áõ)
  • myelopoiesis
    °ñ¼ö(Ç÷±¸)Çü¼º
  • myelopore
    ô¼ö±¸¸Û, ô¼ö°ø
  • myeloproliferative
    °ñ¼öÁõ½Ä-
  • myeloproliferative disorder
    °ñ¼öÁõ½ÄÁúȯ
  • myeloproliferative syndrome
    °ñ¼öÁõ½ÄÁõÈıº
  • myeloradiculitis
    ô¼ö½Å°æ±Ù¿°, ô¼ö½Å°æ»Ñ¸®¿°
  • myeloradiculodysplasia
    ô¼ö½Å°æ»Ñ¸®Çü¼ºÀÌ»ó, ô¼ö½Å°æ±ÙÇü¼ºÀÌ»ó
  • myeloradiculopathy
    ô¼ö½Å°æ»Ñ¸®º´(Áõ), ô¼ö½Å°æ±Ùº´(Áõ)
  • myeloschisis
    ô¼ö°¥¸²(Áõ), ô¼ö¿­(ô±âÐæñ)
  • myelosclerosis
    1. °ñ¼ö°æÈ­(Áõ) 2. ô¼ö°æÈ­(Áõ)
  • myelosis
    1. °ñ¼öÁõ 2. ô¼öÁõ
  • myelospongium
    žƽŰæ°üº®¸Á»óÁ¶Á÷, ô¼öÇØ¸éÁú
  • myelosuppression
    °ñ¼ö¾ïÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • myelopetal
    ô¼öÁÖÇâ-, ô¼öÂÊ-
  • myelophthisic splenomegaly
    °ñ¼öÅ¿Áö¶óºñ´ë, °ñ¼ö·Î¼ººñÀåºñ´ë
  • myelophthisis
    ô¼öȲÆóÁõ, °ñ¼öȲÆóÁõ
  • myelopoiesis
    °ñ¼öÇ÷±¸Çü¼º
  • myelopore
    ô¼ö±¸¸Û
  • myeloproliferative
    °ñ¼öÁõ½Ä-
  • myeloproliferative disorder
    °ñ¼öÁõ½ÄÁúȯ
  • myeloproliferative syndrome
    °ñ¼öÁõ½ÄÁõÈıº
  • myeloradiculitis
    ô¼ö½Å°æ±Ù¿°, ô¼öµÚ»Ñ¸®¿°
  • myeloradiculodysplasia
    ô¼ö»Ñ¸®Çü¼ºÀÌ»ó, ô¼ö½Å°æ±ÙÀÌÇü¼ºÁõ
  • myeloradiculopathy
    ô¼ö»Ñ¸®º´Áõ, ô¼ö½Å°æ±Ùº´Áõ
  • myelorrhagia
    (¢¡hematomyelia) ô¼ö³»ÃâÇ÷
  • myeloschisis
    ô¼ö°¥¸²(Áõ)
  • myelosclerosis
    ô¼ö°æÈ­(Áõ), °ñ¼ö°æÈ­(Áõ)
  • myelosis
    °ñ¼öÁõ, ô¼öÁõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • myelitis haemorrhagica ³ª
    ÃâÇ÷¼º(õóúìàõ) ô¼ö¿°.
  • myelitis lumbalis ³ª
    ¿äºÎô¼ö¿°.
  • myelitis sacralis ³ª
    õºÎô¼ö¿°.
  • myelitis, radiation-induced
    ¹æ»ç¼± À¯¹ß ô¼ö¿°
  • myelo-
    ô¼ö ¹× °ñ¼ö¿Í °ü·ÃµÈ Á¢µÎ¾î
  • myeloarchitectonic ³ª
    ¼öÃʱ¸Ãà(âÐôúϰõé) ÀÇ.
  • myeloblast
    °ñ¼ö¸ð±¸(ÍéâÐٽϹ).
  • myeloblast
    °ñ¼ö¸ð¼¼Æ÷ »À¼ÓÁú¸ð¼¼Æ÷
  • myeloblast
    °ñ¼ö ¸ð¼¼Æ÷
  • myeloblast
    °ñ¼ö¸ð±¸(ÍéâÐٽϹ)
  • myeloblast
    °ñ¼ö¾Æ±¸
  • myeloblast
    °ñ¼ö¾Æ±¸
  • myeloblast
    °ñ¼ö¸ð±¸(ÍéâÐٽϹ)
  • myeloblast
    °ñ¼ö¸ð±¸(Ë­ËàËÎË´).
  • myeloblastic leukemia
    °ñ¼ö¾Æ±¸ ¹éÇ÷º´
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • myelon
    ô¼ö
  • myelopathic
    ô¼öÁõ¼ºÀÇ
  • myelopathy
    ô¼öÁõ, ô¼öÀå¾Ö, °ñ¼öÁõ
  • myeloperoxidase deficiency
    ¸¶ÀÌ¿¤·Î ÆÛ·Ï½Ãµ¥À̽º °áÇÌÁõ
    »ó¿°»öü¼º ¿­¼º ÇüÁú·Î À¯ÀüµÇ¸ç, Áß¼º±¸¿Í ´Ü±¸ÀÇ È£¾ÆÁÖ¸£¼º °ú¸³ ³»¿¡ MPO°¡ ÀüÇô ¾ø´Ù.
  • myelopetal
    ±¸Ã´¼ö¼ºÀÇ
    ô¼ö ¹æÇâÀ¸·Î ¿òÁ÷ÀÌ´Â.
  • myelophthisis
    ô¼ö·Î, °ñ¼ö·Î
    ô¼öÀÇ ¼Ò¸ð.
  • myeloplaque
    °ñ¼ö °Å¼¼Æ÷
  • myeloplax
    °ñ¼ö °Å¼¼Æ÷
    °ñ¼ö¿¡ ÀÖ´Â ´ÙÇÙ °Å´ë ¼¼Æ÷.
  • myelopoiesis
    °ñ¼ö Á¶Ç÷, °ñ¼ö ¹ß»ý
  • myelopore
    ô¼ö°ø
    ô¼ö¿¡ À־ÀÇ °ü ¶Ç´Â °³±¸.
  • myeloproliferative syndrome
    °ñ¼ö Áõ½Ä¼º ÁõÈıº
    Á¶Á÷ Çü¼º»ó ¿¬°üÀÌ ÀÖ´Â Áúȯ ±ºÀ» ÃÑĪÇÏ´Â °ÍÀ¸·Î, ´Ù¾çÇÑ ½Ã±â¿Í ´Ù¾çÇÑ Á¤µµ·Î °ñ¼ö ±¸¼º ¼¼Æ÷ÀÇ Çϳª ȤÀº ±× ÀÌ»óÀÇ ¼¼Æ÷°è»ç °ñ¼ö³» ¹× °ñ¼ö¿Ü·Î Áõ½ÄÇÏ´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù. ±× ±¸¼º ¼¼Æ÷¿¡´Â °ñ¼ö±¸Çü, Àû¾Æ±¸Çü, °ÅÇÙ ¼¼Æ÷ÇüÀÇ ¼¼Æ÷ ¿Ü¿¡ ¼¼¸Á°ú °£¿±°è À¯·¡ÀÇ ¼¼Æ÷µµ Æ÷ÇԵȴÙ. À̵éÀÇ Áõ½Ä¼º Áúȯ¿¡´Â ±Þ¼º ¹× ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´, Áø¼º ´ÙÇ÷Áõ, °ñ¼ö ÀÌÇü¼º, °ñ¼ö ¼¶À¯Á¾, º»Å¼º ÃâÇ÷¼º Ç÷¼ÒÆÇ °¨¼ÒÁõ, ÀûÇ÷±¸ Áõ°¡¼º °ñ¼öÁõ µîÀÌ ÀÖ´Ù.
  • myeloradiculodysplasia
    ô¼ö ½Å°æ±Ù Çü¼º Àå¾Ö
    ô¼ö ¹× ô¼ö ½Å°æ±ÙÀÇ ¹ßÀ° ÀÌ»ó.
  • myelorrhagia
    ô¼ö ÃâÇ÷
  • myelosarcomatosis
    °ñ¼ö À°Á¾Áõ
  • myeloscintogram
    ô¼ö ¼¶±¤µµ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
myelocytic Pertaining to or characterised by myelocytes.
(05 Mar 2000)
myelocytic crisis A temporary but conspicuous and sudden increase in cells of the myelocytic series in the circulating blood.
(05 Mar 2000)
myelocytic leukaemia <haematology, tumour> A form of leukaemia characterised by an uncontrolled proliferation of myelopoietic cells in the bone marrow and in extramedullary sites, and the presence of large numbers of immature and mature granulocytic forms in various tissues (and organs) and in the circulating blood.
The total count may range from 1000 (aleukaemic variety) to several hundred thousand per cu mm. The predominant cell is usually of the neutrophilic series, but, in a few instances, eosinophilic or basophilic granulocytes, or even megakaryocytes, may represent the chief form; early in granulocytic leukaemia, the circulating blood may contain excessive numbers of all of the granulocytic forms.
Synonym: leukaemic myelosis, myelocytic leukaemia, myelogenic leukaemia, myelogenous leukaemia, myeloid leukaemia.
(05 Mar 2000)
myelocytic leukemoid reaction Leukocytosis of at least moderate degree, e.g., 50,000 or more per cu mm, with a few immature forms, e.g., 1 or 2% myelocytes, but chiefly mature polymorphonuclear leukocytes in the circulating blood; may be observed in association with tuberculosis, chronic osteomyelitis, various types of empyema, malaria, pneumococcal pneumonia, meningococcal meningitis, Hodgkin's disease, and metastases of carcinoma in the bone marrow.
(05 Mar 2000)
myelocytoma A nodular focus or fairly well-circumscribed, relatively dense accumulation of myelocytes, as in certain tissues of persons with myelocytic leukaemia.
Origin: myelocyte + G. -oma, tumour
(05 Mar 2000)
myelocytomatosis 1. A form of tumour involving chiefly the myelocytes.
Synonym: leukochloroma.
2. A rare leukosis of fowl marked by the presence of white tumours composed of myeloid cells, located principally along the sternum and in the liver.
(05 Mar 2000)
myelocytosis The occurrence of abnormally large numbers of myelocytes in the circulating blood, or tissues, or both.
Origin: myelocyte + G. -osis, condition
(05 Mar 2000)
myelodiastasis Softening and destruction of the spinal cord.
Origin: myelo-+ G. Diastasis, separation
(05 Mar 2000)
myelodysplasia Abnormal or defective formation of the bone marrow cells.
Origin: Gr. Plassein = to form
(27 Sep 1997)
myelodysplastic syndrome <syndrome> A group of disorders characterised by low white blood cell counts, low platelet counts, and, in some cases, increased monocytes. The primary problem is in the bone marrow cellularity.
(27 Sep 1997)
myelodysplastic syndromes Conditions in which the bone marrow shows qualitative and quantitative changes suggestive of a preleukaemic process, but having a chronic course that does not necessarily terminate as acute leukaemia.
(12 Dec 1998)
myelofibrosis A progressive disease of the bone marrow where neoplastic bone marrow stem cells lodge and grow in multiple sites outside the bone marrow. Typically, there is enlargement of the spleen and a gradual replacement of the bone marrow elements by fibrosis (scarring), progressive anaemia and variable changes in the number of white blood cells and platelets.
Diagnosis is by bone marrow biopsy. There is no definitive treatment for this disorder that has been shown to affect life span favorably.
(27 Sep 1997)
myelogenesis 1. Development of bone marrow.
2. Development of the central nervous system.
3. Formation of myelin around an axon.
(05 Mar 2000)
myelogenetic Myelogenic
1. Relating to myelogenesis.
2. Produced by or originating in the bone marrow.
Synonym: myelogenous.
(05 Mar 2000)
myelogenic <physiology> Derived from, or pertaining to, the bone marrow.
Origin: Gr. Marrow + the root of to be born.
Source: Websters Dictionary
(01 Mar 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 4 ÆäÀÌÁö: 5
  • Myelolipoma - »õâ A rare benign tumor of the adrenal gland, several centimeters in diameter, composed in varying proportions of adipose tissue, lymphocytes, and primitive myeloid cells, probably a developmental abnormality. (Dorland, 27th ed)
    Synonyms : Myelolipomas
  • Myeloma Proteins - »õâ Abnormal immunoglobulins characteristic of MULTIPLE MYELOMA.
    Synonyms : M Components, Proteins, Myeloma
  • Myelopoiesis - »õâ Formation of MYELOID CELLS from the pluripotent HEMATOPOIETIC STEM CELLS in the BONE MARROW via MYELOID STEM CELLS. Myelopoiesis generally refers to the production of leukocytes in blood, such as MONOCYTES and GRANULOCYTES. This process also produces precursor cells for MACROPHAGE and DENDRITIC CELLS found in the lymphoid tissue.
    Synonyms :
  • Myeloproliferative Disorders - »õâ Disorders in which one or more stimuli cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential.
    Synonyms : Disorder, Myeloproliferative, Disorders, Myeloproliferative, Myeloproliferative Disorder
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
myeloma a tumor of the bone marrow (usually malignant) composed of cells normally found in bone marrow
Ãâó: wordnet.princeton.edu/perl/webwn
myelomeningocele a congenital defect of the central nervous system in which a sac containing part of the spinal cord and its meninges protrude through a gap in the vertebral column; frequently accompanied by hydrocephalus and mental retardation
Ãâó: wordnet.princeton.edu/perl/webwn
myelin basic protein (MBP) a basic protein (MW 18,000) that constitutes about 30 per cent of myelin proteins; elevated levels of MBP occur in acute exacerbation of multiple sclerosis and acute cerebral infarction. Immunization of laboratory animals with MBP produces encephalomyelitis by inducing T cell activity that leads to demyelination and lymphoid infiltration. Called also encephalitogenic p.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
myelogenic osteopathy any bone disease due to the impaired relation between the medullary and osseous tissues.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
myeloma protein any of the pathological immunoglobulin proteins or fragments, such as M component and Bence-Jones protein, secreted by myeloma cells.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 5
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á